Pluristem Therapeutics Inc. STOCK OPTION AGREEMENTStock Option Agreement • September 12th, 2019 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Stock Option Agreement and the associated grant award information provided in written form or available in electronic form from the recordkeeper (in either case, “Exhibit A”) for the Pluristem Therapeutics Inc. 2019 Equity Compensation Plan, as amended and in effect from time to time (the “Plan”), is made as of the date shown as the “Date of Grant” in Exhibit A by and between Pluristem Therapeutics Inc. (the “Company”), and the individual identified by Name in Exhibit A (the “Optionee”). This instrument and Exhibit A are collectively referred to as the “Agreement.”
Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • September 12th, 2019 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Restricted Stock Agreement and the associated grant award information provided in written form or available in electronic form from the recordkeeper (in either case, “Exhibit A”) for the Pluristem Therapeutics Inc. 2019 Equity Compensation Plan, as amended and in effect from time to time (the “Plan”), is made as of the date shown as the “Date of Grant” in Exhibit A by and between Pluristem Therapeutics Inc. (the “Company”), and the individual identified by Name in Exhibit A (the “Participant”). This instrument and Exhibit A are collectively referred to as the “Agreement.”
Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • September 12th, 2019 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Restricted Stock Agreement and the associated grant award information provided in written form or available in electronic form from the recordkeeper (in either case, “Exhibit A”) for the Pluristem Therapeutics Inc. 2019 Equity Compensation Plan, as amended and in effect from time to time (the “Plan”), is made as of the date shown as the “Date of Grant” in Exhibit A by and between Pluristem Therapeutics Inc. (the “Company”), and the individual identified by Name in Exhibit A (the “Participant”). This instrument and Exhibit A are collectively referred to as the “Agreement.”
